Your browser doesn't support javascript.
loading
Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis.
Atkinson, John M; Pullen, Nick; Da Silva-Lodge, Michelle; Williams, Lynne; Johnson, Tim S.
Afiliação
  • Atkinson JM; Sheffield Kidney Institute & Academic Nephrology Unit, University of Sheffield, Sheffield, United Kingdom; UCB Celltech Pharmaceuticals, Berkshire, United Kingdom; and.
  • Pullen N; Pfizer Global Research Development, Cambridge, Massachusetts.
  • Da Silva-Lodge M; Sheffield Kidney Institute & Academic Nephrology Unit, University of Sheffield, Sheffield, United Kingdom;
  • Williams L; Sheffield Kidney Institute & Academic Nephrology Unit, University of Sheffield, Sheffield, United Kingdom;
  • Johnson TS; Sheffield Kidney Institute & Academic Nephrology Unit, University of Sheffield, Sheffield, United Kingdom; UCB Celltech Pharmaceuticals, Berkshire, United Kingdom; and t.johnson@sheffield.ac.uk.
J Am Soc Nephrol ; 26(8): 1925-37, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25411467
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article